CUTANEOUS MALIGNANT MELANOMA
Clinical trials for CUTANEOUS MALIGNANT MELANOMA explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS MALIGNANT MELANOMA trials appear
Sign up with your email to follow new studies for CUTANEOUS MALIGNANT MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental virus vaccine takes on multiple cancers in early trial
Disease control Recruiting nowThis early-phase trial is testing a new virus-based cancer vaccine (PeptiCRAd-1) combined with the immunotherapy drug pembrolizumab in 15 people with various solid tumors like melanoma, triple-negative breast cancer, and lung cancer. The main goal is to see if the combination is …
Matched conditions: CUTANEOUS MALIGNANT MELANOMA
Phase: PHASE1 • Sponsor: Valo Therapeutics Oy • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Could six months of immunotherapy be enough for melanoma? major trial launches
Disease control Recruiting nowThis large phase 3 trial is testing whether giving immunotherapy for 6 months after surgery for high-risk melanoma is as effective as the standard 12-month course. The study aims to enroll 1,792 adults who have had their melanoma surgically removed. If shorter treatment works, it…
Matched conditions: CUTANEOUS MALIGNANT MELANOMA
Phase: PHASE3 • Sponsor: Uppsala University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
App aims to help melanoma survivors catch skin cancer early
Knowledge-focused Recruiting nowThis study tests whether a digital tool called MySmartSkin can help melanoma survivors do better skin self-exams. About 385 survivors will use either the enhanced app or a standard educational webpage. The goal is to see if the app leads to more thorough skin checks and earlier d…
Matched conditions: CUTANEOUS MALIGNANT MELANOMA
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC